--- title: UgenTec raises 1.4M in seed funding description: We are proud to announce that we have received more than €1M in venture capital funding from a group of Belgian investors. image: https://www.ugentec.com/hubfs/ugentec/Blog/WU-TM.png --- [![UgenTec](https://www.ugentec.com/hubfs/ugentec/ugentec-home/ugentec-logo.png)](https://www.ugentec.com) [![Start with FastFinder](https://no-cache.hubspot.com/cta/default/2387197/150e1f23-63f3-4350-a085-dd94e8bd65f6.png)](https://cta-redirect.hubspot.com/cta/redirect/2387197/150e1f23-63f3-4350-a085-dd94e8bd65f6) [![Logo_FullColor_Large_Transp](https://www.ugentec.com/hs-fs/hubfs/Logo_FullColor_Large_Transp.png?width=98&height=44&name=Logo_FullColor_Large_Transp.png "Logo_FullColor_Large_Transp")](https://www.ugentec.com/) [Back to blog](https://www.ugentec.com/en-us/blog) # V3 UgenTec raises 1.4M in seed funding [Wouter Uten](https://www.ugentec.com/en-us/blog/author/wouter-uten) | [Funding](https://www.ugentec.com/en-us/blog/tag/funding) | 23/03/2021 [![](https://www.ugentec.com/hubfs/ugentec/Blog/WU-TM.png) ](https://www.ugentec.com/en-us/blog/ugentec-has-raised-1.4m-in-seed-funding-0) We are proud to announce that we have received more than €1M in venture capital funding from a group of Belgian investors and an additional €250 000 in research funds from the [IWT](http://www.iwt.be), a government agency for Innovation by Science and Technology. The investors include former MedHold CEO [Annie Vereecken](https://be.linkedin.com/in/annie-vereecken-ab8587102), Cartagenia CEO [Herman Verrelst](https://www.linkedin.com/in/hermanverrelst) and a KULeuven investment group led by professor [Bart De Moor](http://www.kuleuven.be/wieiswie/nl/person/00008904). [LRM](http://www.lrm.be), a Belgian investment company, will also support UgenTec with a loan of €100,000. Read the [official press release](http://www.prnewswire.com/news-releases/belgian-start-up-ugentec-receives-funding-from-european-investors-300063924.html). Read the article in [Genomeweb](https://www.genomeweb.com/business-news/ugentec-raises-14m-investors-government-agency). [![](https://www.ugentec.com/hubfs/2019SEP09-Grant-header-final@2x.png) ](https://www.ugentec.com/en-us/blog/epidemiological-monitoring-and-prediction-grant-0) ### [Innovating in epidemiological monitoring and prediction](https://www.ugentec.com/en-us/blog/epidemiological-monitoring-and-prediction-grant-0) UgenTec, an innovative software provider for molecular diagnostics, today announced it won a $550,000 (€490,000) grant from the Flemish government (VL... [![](https://www.ugentec.com/hubfs/AACampaigns/SERIESA/SERIESA-header-blog.png) ](https://www.ugentec.com/en-us/blog/series-a-0) ### [Announcing our $ 9.3 million Series A funding](https://www.ugentec.com/en-us/blog/series-a-0) We're excited to announce our series A funding round. Existing and new investors subscribed to the round for a total worth of $9,3 million (€7,5 milli... [![](https://www.ugentec.com/hubfs/AACampaigns/H2020/H2020-emailheader@2x.png) ](https://www.ugentec.com/en-us/blog/press-release-horizon2020-0) ### [UgenTec receives prestigious €50.000 European Horizon 2020 innovation grant](https://www.ugentec.com/en-us/blog/press-release-horizon2020-0) BRUSSELS, BELGIUM and HASSELT, BELGIUM—. UgenTec, the Belgian PCR automation software company is approved for the SME Instrument Phase 1 by the Europe... [![](https://www.ugentec.com/hubfs/ugentec/Blog/NewFundslarge.png) ](https://www.ugentec.com/en-us/blog/ugentec-raises-2.15m-in-post-seed-funding-0) ### [V3 We've raised 2.15M in post-seed funding!](https://www.ugentec.com/en-us/blog/ugentec-raises-2.15m-in-post-seed-funding-0) UgenTec, the Belgian company that is developing independent PCR analysis software based on artificial intelligence and machine learning, closed a €2.1... [Back to blog](https://www.ugentec.com/en-us/blog) [![Start with FastFinder](https://no-cache.hubspot.com/cta/default/2387197/150e1f23-63f3-4350-a085-dd94e8bd65f6.png)](https://cta-redirect.hubspot.com/cta/redirect/2387197/150e1f23-63f3-4350-a085-dd94e8bd65f6) ![Imec](https://www.ugentec.com/hubfs/2018-Web-3/20181126-imec.svg) ![ESF](https://www.ugentec.com/hubfs/2018-Web-3/20181126-ESF-.svg) ![Horizon 2020](https://www.ugentec.com/hubfs/2018-Web-3/20181126-Horizon.svg) ![Vlaanderen](https://www.ugentec.com/hubfs/2018-Web-3/20181126-Vlaanderen-verbeelding.svg) ![Vlaanderen](https://www.ugentec.com/hubfs/EIT-Accelerator.svg) For the latest version of the instructions for use, click [this link](https://ugentecpublicwesteurope.blob.core.windows.net/platformversion/IFU%20FastFinder.pdf). IFU in paper format can be requested at [support@ugentec.com](mailto:support@ugentec.com). ![UgenTec](https://www.ugentec.com/hubfs/2018-Web-3/20181126-UgenTec-White.svg) Copyright 2026 - ** Kempische Steenweg 303/105, 3500 Hasselt Belgium ([map](https://goo.gl/maps/LHmus7PvixBf9ogr7)) - ** 1 Mifflin Place, Suite 400 Cambridge, MA 02138, USA ([map](https://goo.gl/maps/KjJ7RuC17pSCc2tz9)) - [Legal documents](https://www.ugentec.com/legal) Contact: [info@ugentec.com](mailto:info@ugentec.com) | [+32 78 48 44 79](tel:+32%2078%2048%2044%2079) | VAT number: BE05 5197 6421 ![](https://ws.zoominfo.com/pixel/iwxC1M4Vx04kk8t3iG7S) ![](https://www.facebook.com/tr?id=165929623819142&ev=PageView&noscript=1) ![](https://googleads.g.doubleclick.net/pagead/viewthroughconversion/846398553/?guid=ON&script=0/)